Futura Medical plc (AIM: FUM), the pharmaceutical company developing innovative sexual health products, today announces that the Mexican Secretariat of Health has granted over the counter sale (“OTC”) Marketing Authorisation for Eroxon®, the Company’s breakthrough, topical gel formulation for the treatment of erectile dysfunction (“ED”). Read more…
Futura Medical plc (AIM: FUM), the pharmaceutical company developing innovative sexual health products, today announces that Eroxon® is now available for purchase online through the BinSina Pharmacy in the United Arab Emirates, the first market in the Middle East to stock the product. Read more…
Recently acquired Sanofi portfolio products to be combined with acquired Libber Pharma infrastructure to build new affiliate in Brazil Products in Mexico to be distributed through newly established greenfield affiliate Barcelona and Düsseldorf – July 11, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) […]
